Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Profit After Tax (2014 - 2026)

Ocugen's (OCGN) quarterly Profit After Tax came in at -$19.2 million in Q1 2026, down 25.02% YoY from -$25.6 million in Q1 2025, and down 8.72% on a QoQ basis from -$17.7 million in Q4 2025.

Analysis

Ocugen (OCGN) Profit After Tax (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Profit After Tax data on file, last reported at -$19.2 million in Q1 2026.

  • Quarterly Profit After Tax fell 25.02% year-over-year to -$19.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$71.6 million (down 24.75% YoY) and the FY2025 annual result came in at -$67.8 million, down 25.5% from the prior year.
  • Profit After Tax fell to -$19.2 million in Q1 2026, from -$17.7 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$11.0 million in Q4 2023 to a low of -$23.9 million in Q3 2022.
  • A 5-year average of -$17.1 million and a median of -$17.3 million in 2023 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2022 — Profit After Tax sank 168.69% — and 2023, when it jumped 51.0%.
  • Tracing OCGN's Profit After Tax over 5 years: stood at -$22.4 million in 2022, then surged by 50.89% to -$11.0 million in 2023, then fell by 25.69% to -$13.8 million in 2024, then dropped by 27.73% to -$17.7 million in 2025, then dropped by 8.72% to -$19.2 million in 2026.
  • The last three Profit After Tax figures came in at -$19.2 million (Q1 2026), -$17.7 million (Q4 2025), and -$20.1 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -16.62 Mn
10 Ocugen 458.91 Mn 358.81 Mn - -24.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.90 Mn
Mar 31, 2026 -19.18 Mn
Dec 31, 2025 -17.71 Mn
Sep 30, 2025 -20.05 Mn
Jun 30, 2025 -14.77 Mn
Mar 31, 2025 -15.35 Mn
Dec 31, 2024 -13.90 Mn
Sep 30, 2024 -12.98 Mn
Jun 30, 2024 -15.28 Mn
Mar 31, 2024 -11.92 Mn
Dec 31, 2023 -10.99 Mn
Sep 30, 2023 -11.72 Mn
Jun 30, 2023 -23.07 Mn
Mar 31, 2023 -17.33 Mn
Dec 31, 2022 -22.39 Mn
Sep 30, 2022 -23.91 Mn
Jun 30, 2022 -21.48 Mn
Mar 31, 2022 -19.02 Mn
Dec 31, 2021 -14.62 Mn
Sep 30, 2021 -10.76 Mn